Back to 
MOORE CAPITAL MANAGEMENT, LP
MOORE CAPITAL MANAGEMENT, LP
TGTX
Showing 0 of 2 quarters
Position history for MOORE CAPITAL MANAGEMENT, LP's holdings in TG THERAPEUTICS INC
No. Moore Capital Management exited its TGTX (TG Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 97,635 shares worth $816,229. Moore Capital Management first reported TGTX in Q3 2023 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.